Cel The market for testing of pharmaceuticals and the demand for human cells for cell therapies will grow substantially. Conventional cell culture and organ- model systems (C-CCW) are complex and expensive, due to chemical coating compounds requiring multiple production steps, and marginally effective as cells stay alive for short periods and/or grow at low speed. The performance of cell culture systems and organ model systems can be dramatically improved by using materials with designed surface topography. Materiomics has invented an innovative TopoChip high-throughput screening technology. The overall aim is to innovatively set up enabling technology to transfer the designed topographies to C-CCW products in a high-volume, low-cost manufacturing process (leading to phase 2 application). It creates the next generation products: Functionalized Cell Culture Ware ( F-CCW )which is simple, highly effective and efficient. Goals in Phase 1 are to:1. Demonstrate the technical feasibility of transferring designed topographies on C-CCW2. Explore commercial feasibility of F-CCW: to develop a business plan. 3. Develop production methods for producing F-CCW4. Select cell culture system applications that allow for the highest expected economic return on investment. 5. Identify (and contact) network partnerships for creating a production facility for F-CCW’sPotential end users are research driven industries of drug development, toxicology, personalized medicine and cell therapeutics. Potential stakeholders are investors, injection moulding specialists, manufacturers of moulds for inlay, testing and research laboratories for medical and toxicological testing and pharmaceutical industry. The market is a global market (EU, US and upcoming Asian markets).F-CCW is a breakthrough in functionality of cell culture. Since F-CCW is not limited to one application only, F-CCW will offer multiple follow-up investment opportunities and create many opportunities for new venture Dziedzina nauki engineering and technologymechanical engineeringmanufacturing engineeringmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsnatural sciencesphysical sciencesastronomyplanetary sciencesplanetary geologyengineering and technologymaterials engineeringcoating and filmsmedical and health sciencesmedical biotechnologycells technologies Program(-y) H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Temat(-y) NMP-25-2015-1 - Accelerating the uptake of nanotechnologies, advanced materials or advanced manufacturing and processing technologies by SMEs Zaproszenie do składania wniosków H2020-SMEInst-2014-2015 Zobacz inne projekty w ramach tego zaproszenia Szczegółowe działanie H2020-SMEINST-1-2015 System finansowania SME-1 - SME instrument phase 1 Koordynator MATERIOMICS BV Wkład UE netto € 50 000,00 Adres OXFORDLAAN 70 6229 EV MAASTRICHT Niderlandy Zobacz na mapie MŚP Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant. Tak Region Zuid-Nederland Limburg (NL) Zuid-Limburg Rodzaj działalności Private for-profit entities (excluding Higher or Secondary Education Establishments) Linki Kontakt z organizacją Opens in new window Uczestnictwo w unijnych programach w zakresie badań i innowacji Opens in new window sieć współpracy HORIZON Opens in new window Koszt całkowity € 71 429,00
